Barlogie B, Johnston DA, Keating M, et al. Evolution of oligoleukemia. Cancer. 1984 May 15. 53(10):2115-24. [QxMD MEDLINE Link].
Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. 3rd ed. International Agency for Research on Cancer (IARC); 2001.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun. 51(2):189-99. [QxMD MEDLINE Link].
Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer (IARC); 2008.
Bhatt VR, Steensma DP. Hematopoietic Cell Transplantation for Myelodysplastic Syndromes. J Oncol Pract. 2016 Sep. 12 (9):786-92. [QxMD MEDLINE Link]. [Full Text].
Bierings M, Nachman JB, Zwaan CM. Stem cell transplantation in pediatric leukemia and myelodysplasia: state of the art and current challenges. Curr Stem Cell Res Ther. 2007 Jan. 2(1):53-63. [QxMD MEDLINE Link].
Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009 Nov 5. 361(19):1872-85. [QxMD MEDLINE Link].
Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia--a review. Br J Haematol. 2008 Jan. 140(2):123-32. [QxMD MEDLINE Link].
Kalra R, Paderanga DC, Olson K, Shannon KM. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood. 1994 Nov 15. 84(10):3435-9. [QxMD MEDLINE Link].
Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med. 1994 Mar 3. 330(9):597-601. [QxMD MEDLINE Link].
Ortmann CA, Niemeyer CM, Wawer A, Ebell W, Baumann I, Kratz CP. TERC mutations in children with refractory cytopenia. Haematologica. 2006 May. 91(5):707-8. [QxMD MEDLINE Link].
Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, Killick S, et al. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica. 2007 Aug. 92(8):1013-20. [QxMD MEDLINE Link].
Vidal DO, Paixao VA, Brait M, et al. Aberrant methylation in pediatric myelodysplastic syndrome. Leuk Res. 2007 Feb. 31(2):175-81. [QxMD MEDLINE Link].
Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia. 1995 Sep. 9(9):1569-72. [QxMD MEDLINE Link].
Emanuel PD. Myelodysplasia and myeloproliferative disorders in childhood: an update. Br J Haematol. 1999 Jun. 105(4):852-63. [QxMD MEDLINE Link].
Hasle H, Jacobsen BB, Pedersen NT. Myelodysplastic syndromes in childhood: a population based study of nine cases. Br J Haematol. 1992 Aug. 81(4):495-8. [QxMD MEDLINE Link].
Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol. 2003 Jun. 121(5):758-67. [QxMD MEDLINE Link].
Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM. Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2004. 118-45. [QxMD MEDLINE Link].
Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol. 1992 Oct. 82(2):358-67. [QxMD MEDLINE Link].
Arico M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood. 1997 Jul 15. 90(2):479-88. [QxMD MEDLINE Link].
Kardos G, Baumann I, Passmore SJ, Locatelli F, Hasle H, Schultz KR. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood. 2003 Sep 15. 102(6):1997-2003. [QxMD MEDLINE Link].
Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 2007. 109(1):46-51.
Zubovic L, Piazza S, Tebaldi T, et al. The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing. J Hematol Oncol. 2020 Oct 12. 13 (1):135. [QxMD MEDLINE Link]. [Full Text].
Hasle H. Myelodysplastic and myeloproliferative disorders in children. Curr Opin Pediatr. 2007 Feb. 19(1):1-8. [QxMD MEDLINE Link].
Barnard DR, Woods WG. Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update. Leuk Lymphoma. 2005 May. 46(5):651-63. [QxMD MEDLINE Link].
Tragiannidis A, Gombakis N, Papageorgiou M, Hatzipantelis E, Papageorgiou T, Hatzistilianou M. Treatment-related myelodysplastic syndrome (t-MDS)/acute myeloid leukemia (AML) in children with cancer: A single-center experience. Int J Immunopathol Pharmacol. 2016 Dec. 29 (4):729-30. [QxMD MEDLINE Link].
Teo JT, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J. Clinical and genetic analysis of unclassifiable inherited bone marrow failure syndromes. Pediatrics. 2008 Jul. 122(1):e139-48. [QxMD MEDLINE Link].
Oliveira AF, Tansini A, Vidal DO, Lopes LF, Metze K, Lorand-Metze I. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2017 Apr. 64 (4):[QxMD MEDLINE Link].
Auletta JJ, Shurin S. Improved hematopoiesis using amifostine in secondary myelodysplasia. J Pediatr Hematol Oncol. 1999 Nov-Dec. 21(6):531-4. [QxMD MEDLINE Link].
Bader-Meunier B, Mielot F, Tchernia G, et al. Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol. 1996 Feb. 92(2):344-50. [QxMD MEDLINE Link].
Mandel K, Dror Y, Poon A, Freedman MH. A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC system. J Pediatr Hematol Oncol. 2002 Oct. 24(7):596-605. [QxMD MEDLINE Link].
Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003 Feb. 17(2):277-82. [QxMD MEDLINE Link].
Occhipinti E, Correa H, Yu L, Craver R. Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders. Pediatr Blood Cancer. 2005 Mar. 44(3):240-4. [QxMD MEDLINE Link].
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30. 114(5):937-51. [QxMD MEDLINE Link].
Vardiman JW. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2006. 199-204. [QxMD MEDLINE Link].
Gupta V, Brooker C, Tooze JA, Yi QL, Sage D, Turner D. Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. Br J Haematol. 2006 Jul. 134(1):95-9. [QxMD MEDLINE Link].
Bortnick R, Wlodarski M, de Haas V, et al. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome. Bone Marrow Transplant. 2021 Jul 9. [QxMD MEDLINE Link]. [Full Text].
Sharma A, Li Y, Huang S, et al. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS. Bone Marrow Transplant. 2021 Aug. 56 (8):1866-75. [QxMD MEDLINE Link].
Bunin N, Saunders F, Leahey A, et al. Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol. 1999 Nov-Dec. 21(6):479-85. [QxMD MEDLINE Link].
Kalwak K, Wojcik D, Gorczynska E, et al. Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative?. Transplant Proc. 2004 Jun. 36(5):1574-7. [QxMD MEDLINE Link].
Mantadakis E, Shannon KM, Singer DA, Finklestein J, Chan KW, Hilden JM. Transient monosomy 7: a case series in children and review of the literature. Cancer. 1999 Jun 15. 85(12):2655-61. [QxMD MEDLINE Link].
Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Pediatr Blood Cancer. 2007 Jul. 49(1):17-22. [QxMD MEDLINE Link].
Bennett JM. Classification of the myelodysplastic syndromes. Clin Haematol. 1986 Nov. 15(4):909-23. [QxMD MEDLINE Link].
Boogaerts MA, Nelissen V, Roelant C, Goossens W. Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol. 1983 Oct. 55(2):217-27. [QxMD MEDLINE Link].
Cheson BD, Greenberg PL, Bennett JM, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006 Jul 15. 108(2):419-25. [QxMD MEDLINE Link].
Clark R, Peters S, Hoy T, et al. Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. N Engl J Med. 1986 Jun 5. 314(23):1472-5. [QxMD MEDLINE Link].
De Witte T, Van Biezen A, Hermans J, et al. Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Blood. 1997 Nov 15. 90(10):3853-7. [QxMD MEDLINE Link]. [Full Text].
Dewald GW, Pierre RV, Phyliky RL. Three patients with structurally abnormal X chromosomes, each with Xq13 breakpoints and a history of idiopathic acquired sideroblastic anemia. Blood. 1982 Jan. 59(1):100-5. [QxMD MEDLINE Link].
Fohlmeister I, Fischer R, Mödder B, Rister M, Schaefer HE. Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol. 1985 Nov. 38(11):1218-24. [QxMD MEDLINE Link]. [Full Text].
Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000 Jul 15. 96(2):429-36. [QxMD MEDLINE Link]. [Full Text].
Golde DW. The stem cell. Sci Am. 1991 Dec. 265(6):86-93. [QxMD MEDLINE Link].
Hasegawa D, Manabe A, Kubota T, et al. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia. Br J Haematol. 2005 Mar. 128(6):805-12. [QxMD MEDLINE Link].
Hasle H, Arico M, Basso G, et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia. 1999 Mar. 13(3):376-85. [QxMD MEDLINE Link].
Hasle H, Baumann I, Bergstrasser E, et al. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia. 2004 Dec. 18(12):2008-14. [QxMD MEDLINE Link].
Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999 May 27. 340(21):1649-60. [QxMD MEDLINE Link].
Hofmann WK, Ottmann OG, Ganser A, Hoelzer D. Myelodysplastic syndromes: clinical features. Semin Hematol. 1996 Jul. 33(3):177-85. [QxMD MEDLINE Link].
Ingram W, Lim ZY, Mufti GJ. Allogeneic transplantation for myelodysplastic syndrome (MDS). Blood Rev. 2006 Jun 5. [QxMD MEDLINE Link].
Jackson GH, Carey PJ, Cant AJ, et al. Myelodysplastic syndromes in children [letter]. Br J Haematol. 1993 May. 84(1):185-6. [QxMD MEDLINE Link].
Jacobs RH, Cornbleet MA, Vardiman JW, et al. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 1986 Jun. 67(6):1765-72. [QxMD MEDLINE Link].
Juneja SK, Imbert M, Jouault H, Scoazec JY, Sigaux F, Sultan C. Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases. J Clin Pathol. 1983 Oct. 36(10):1129-35. [QxMD MEDLINE Link]. [Full Text].
Kahn A. Abnormalities of erythrocyte enzymes in dyserythropoiesis and malignancies. Clin Haematol. 1981 Feb. 10(1):123-38. [QxMD MEDLINE Link].
Koeffler HP, Golde DW. Human preleukemia. Ann Intern Med. 1980 Aug. 93(2):347-53. [QxMD MEDLINE Link].
Larson RA. Myelodysplasia: when to treat and how. Best Pract Res Clin Haematol. 2006. 19(2):293-300. [QxMD MEDLINE Link].
Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood. 2009 Aug 27. 114(9):1859-63. [QxMD MEDLINE Link]. [Full Text].
Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999 Jan 15. 93(2):459-66. [QxMD MEDLINE Link]. [Full Text].
Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood. 1995 Apr 15. 85(8):1985-99. [QxMD MEDLINE Link]. [Full Text].
Maldonado JE, Maigne J, Lecoq D. Comparative electron-microscopic study of the erythrocytic line in refractory anemia (preleukemia) and myelomonocytic leukemia. Nouv Rev Fr Hematol Blood Cells. 1976. 17(1-2):167-85. [QxMD MEDLINE Link].
Martin S, Baldock SC, Ghoneim AT, Child JA. Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol. 1983 Oct. 36(10):1120-8. [QxMD MEDLINE Link]. [Full Text].
McKenna RW. Myelodysplasia and myeloproliferative disorders in children. Am J Clin Pathol. 2004 Dec. 122 Suppl:S58-69. [QxMD MEDLINE Link].
Mecucci C, Tricot G, Boogaerts M, Van den Berghe H. An identical translocation between chromosome 1 and 15 in two patients with myelodysplastic syndromes [published erratum appears in Br J Haematol 1987 Apr;65(4):508]. Br J Haematol. 1986 Mar. 62(3):439-45. [QxMD MEDLINE Link].
Moir DJ, Jones PA, Pearson J, et al. A new translocation, t(1;3) (p36;q21), in myelodysplastic disorders. Blood. 1984 Aug. 64(2):553-5. [QxMD MEDLINE Link].
Nand S, Godwin JE. Hypoplastic myelodysplastic syndrome. Cancer. 1988 Sep 1. 62(5):958-64. [QxMD MEDLINE Link].
Negendank W, Weissman D, Bey TM, et al. Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders. Blood. 1991 Dec 1. 78(11):2872-9. [QxMD MEDLINE Link]. [Full Text].
Newman DR, Pierre RV, Linman JW. Studies on the diagnostic significance of hemoglobin F levels. Mayo Clin Proc. 1973 Mar. 48(3):199-202. [QxMD MEDLINE Link].
Niemeyer CM, Baumann I. Myelodysplastic syndrome in children and adolescents. Semin Hematol. 2008 Jan. 45(1):60-70. [QxMD MEDLINE Link].
O'Donnell MR, Nademanee AP, Snyder DS, et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol. 1987 Nov. 5(11):1822-6. [QxMD MEDLINE Link].
Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993 Jun 1. 81(11):2844-53. [QxMD MEDLINE Link].
Passmore SJ, Hann IM, Stiller CA, et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood. 1995 Apr 1. 85(7):1742-50. [QxMD MEDLINE Link]. [Full Text].
Raskind WH, Tirumali N, Jacobson R, et al. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood. 1984 Jun. 63(6):1318-23. [QxMD MEDLINE Link].
Rosenthal DS, Moloney WC. Refractory dysmyelopoietic anemia and acute leukemia. Blood. 1984 Feb. 63(2):314-8. [QxMD MEDLINE Link].
Russell NH, Keenan JP, Bellingham AJ. Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity. Br J Haematol. 1979 Mar. 41(3):417-25. [QxMD MEDLINE Link].
Ruter B, Wijermans PW, Lubbert M. Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patients. Cancer. 2006 Apr 15. 106(8):1744-50. [QxMD MEDLINE Link].
Sasaki H, Manabe A, Kojima S, et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia. 2001 Nov. 15(11):1713-20. [QxMD MEDLINE Link].
Scheres JM, Hustinx TW, Holdrinet RS, et al. Translocation 1;7 in dyshematopoiesis: possibly induced with a nonrandom geographic distribution. Cancer Genet Cytogenet. 1984 Aug. 12(4):283-94. [QxMD MEDLINE Link].
Schulman I, Pierce M. Studies on thrombopoiesis.I.A factor in normal plasma required for platelet production; chronic thrombocytopenia due to its deficiency. Blood. 1960. 16:943.
Scoazec JY, Imbert M, Crofts M, et al. Myelodysplastic syndrome or acute myeloid leukemia? A study of 28 cases presenting with borderline features. Cancer. 1985 May 15. 55(10):2390-4. [QxMD MEDLINE Link].
Silverman LR, Mufti GJ. Methylation inhibitor therapy in the treatment of myelodysplastic syndrome. Nat Clin Pract Oncol. 2005 Dec. 2 Suppl 1:S12-23. [QxMD MEDLINE Link].
Sun EC, Yen YM, Ip T, Otsuka NY. Peripheral circulation in patients with myelodysplasia. J Pediatr Orthop. 2003 Nov-Dec. 23(6):714-7. [QxMD MEDLINE Link].
Takagi S, Tanaka O, Origasa H, Miura Y. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes. J Clin Oncol. 1999 Jan. 17(1):277-83. [QxMD MEDLINE Link].
Tricot G, De Wolf-Peeters C, Hendrickx B, Verwilghen RL. Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol. 1984 Jul. 57(3):423-30. [QxMD MEDLINE Link].
Tricot G, De Wolf-Peeters C, Vlietinck R, Verwilghen RL. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol. 1984 Oct. 58(2):217-25. [QxMD MEDLINE Link].
Tricot G, De Wolf-Peeters C, Vlietinck R, Verwilghen RL. The importance of bone marrow biopsy in myelodysplastic disorders. Bibl Haematol. 1984. (50):31-40. [QxMD MEDLINE Link].
Woodard P, Barfield R, Hale G, et al. Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome. Pediatr Blood Cancer. 2005 Sep 9. [QxMD MEDLINE Link].
Woods WG, Barnard DR, Alonzo TA, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol. 2002 Jan 15. 20(2):434-40. [QxMD MEDLINE Link].
Woolfrey AE, Gooley TA, Sievers EL, et al. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome. Blood. 1998 Nov 15. 92(10):3546-56. [QxMD MEDLINE Link]. [Full Text].
Yoshida Y, Oguma S, Uchino H, Maekawa T. Refractory myelodysplastic anaemias with hypocellular bone marrow. J Clin Pathol. 1988 Jul. 41(7):763-7. [QxMD MEDLINE Link]. [Full Text].
Yusuf U, Frangoul HA, Gooley TA, et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant. 2004 Apr. 33(8):805-14. [QxMD MEDLINE Link].